Danny Hsu: THANZ Highlights Antiphospholipid Syndrome in Upcoming Educational Webinar
Danny Hsu, President of THANZ, Director of Therapeutic Apheresis, Immune and Obstetric Haematology at South Western Sydney Local Health District, shared Thrombosis and Haemostasis Society of Australia and New Zealand’s post on LinkedIn:
“a-P-T-T, a-P-T-T, a-P-T-T, a-P-T-T…
Move over ROSÉ and Bruno Mars, the only ‘APT’ we haematologists are singing about this week is the prolonged aPTT!
If you want to untangle classic coagulation paradoxes and dive deep into the latest in Antiphospholipid Syndrome (APS), you will not want to miss our next Thrombosis and Haemostasis Society of Australia and New Zealand educational webinar.
Whether you are tackling tricky lupus anticoagulant assays or managing complex thrombosis, our expert panel will be delivering a session packed with practice-changing clinical pearls.
Join the conversation and secure your spot via the link below.
See you there!”
Thrombosis and Haemostasis Society of Australia and New Zealand shared a post on LinkedIn:
“Remember to register to the THANZ Webinar on Antiphospholipid Syndrome!”
Other posts featuring Danny Hsu on Hemostasis Today.
-
Nov 12, 2026, 13:04Wuhan Thrombosis Congress 2026 – Bringing Global Experts Together – ISTH
-
Nov 12, 2026, 13:00Abdul Mannan: Factor IX Prophylaxis – Can Breakthrough Bleeding Still Occur?
-
Nov 12, 2026, 12:55Clara N.: A United Effort to Reduce the Burden of SCD in Uganda
-
Nov 12, 2026, 12:38Sophia Delicou: Greece and Cyprus Unite to Advance Thalassaemia and Sickle Cell Care
-
Nov 12, 2026, 12:36Wolfgang Miesbach: Three Cleavages, One Key to Factor VIII Activation
-
Nov 12, 2026, 12:04Yazan Abou-Ismail: Pleasure Discussing Factor 11 Inhibitors with Nashwa Abdulsalam at Heart Rhythm TV
-
Nov 12, 2026, 11:57Javed Anees: Asundexian – A New Era in Secondary Stroke Prevention
-
Nov 12, 2026, 10:30Nancy Di Salvo: Protecting Access to IVIG and SCIG – A Call for Continued EU Recognition
-
Nov 12, 2026, 10:28Ali Hammed: Should DOAC Use Exclude Patients From Thrombolysis After Ischemic Stroke?